MedAvail Holdings, Inc. (NASDAQ: MDVL) Stock Competitors & Peer Comparison
See MDVL's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for MDVL and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MDVL | $1.80 | -43.22% | 2.9M | -0.05 | -$35.56 | N/A |
| RPRX | $66.52 | -0.98% | 29.6B | 12.67 | $5.25 | +1.38% |
| WBA | $11.98 | +0.50% | 10.4B | -1.64 | -$7.29 | +4.17% |
| CORT | $80.46 | -0.81% | 8.7B | 229.89 | $0.35 | N/A |
| KNSA | $90.80 | -1.56% | 7.1B | 69.77 | $1.30 | N/A |
| LQDA | $41.85 | -7.12% | 3.7B | 30.55 | $1.37 | N/A |
| PBH | $49.73 | +1.37% | 2.4B | 11.26 | $4.42 | N/A |
| HROWL | $25.61 | +0.19% | 1.4B | N/A | N/A | N/A |
| HROWM | $26.03 | -0.08% | 1.3B | N/A | N/A | N/A |
| LTGO | $13.51 | -3.15% | 811.5M | -5.35 | -$2.52 | N/A |
Stock Comparison
Royalty Pharma plc (NASDAQ: RPRX)
MDVL vs RPRX Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, RPRX has a market cap of 29.6B. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while RPRX trades at $66.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas RPRX's P/E ratio is 12.67. In terms of profitability, MDVL's ROE is -2.39%, compared to RPRX's ROE of +0.12%. Regarding short-term risk, MDVL is more volatile compared to RPRX. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check RPRX's competition here
Walgreens Boots Alliance, Inc. (NASDAQ: WBA)
MDVL vs WBA Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, WBA has a market cap of 10.4B. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while WBA trades at $11.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas WBA's P/E ratio is -1.64. In terms of profitability, MDVL's ROE is -2.39%, compared to WBA's ROE of -0.57%. Regarding short-term risk, MDVL is more volatile compared to WBA. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check WBA's competition here
Corcept Therapeutics Incorporated (NASDAQ: CORT)
MDVL vs CORT Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, CORT has a market cap of 8.7B. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while CORT trades at $80.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas CORT's P/E ratio is 229.89. In terms of profitability, MDVL's ROE is -2.39%, compared to CORT's ROE of +0.08%. Regarding short-term risk, MDVL is more volatile compared to CORT. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check CORT's competition here
Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA)
MDVL vs KNSA Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, KNSA has a market cap of 7.1B. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while KNSA trades at $90.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas KNSA's P/E ratio is 69.77. In terms of profitability, MDVL's ROE is -2.39%, compared to KNSA's ROE of +0.17%. Regarding short-term risk, MDVL is more volatile compared to KNSA. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check KNSA's competition here
Liquidia Corporation (NASDAQ: LQDA)
MDVL vs LQDA Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, LQDA has a market cap of 3.7B. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while LQDA trades at $41.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas LQDA's P/E ratio is 30.55. In terms of profitability, MDVL's ROE is -2.39%, compared to LQDA's ROE of +1.50%. Regarding short-term risk, MDVL is more volatile compared to LQDA. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check LQDA's competition here
Prestige Consumer Healthcare Inc. (NYSE: PBH)
MDVL vs PBH Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, PBH has a market cap of 2.4B. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while PBH trades at $49.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas PBH's P/E ratio is 11.26. In terms of profitability, MDVL's ROE is -2.39%, compared to PBH's ROE of +0.09%. Regarding short-term risk, MDVL is more volatile compared to PBH. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check PBH's competition here
Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ: HROWL)
MDVL vs HROWL Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, HROWL has a market cap of 1.4B. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while HROWL trades at $25.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas HROWL's P/E ratio is N/A. In terms of profitability, MDVL's ROE is -2.39%, compared to HROWL's ROE of -1.04%. Regarding short-term risk, MDVL is more volatile compared to HROWL. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check HROWL's competition here
Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ: HROWM)
MDVL vs HROWM Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, HROWM has a market cap of 1.3B. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while HROWM trades at $26.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas HROWM's P/E ratio is N/A. In terms of profitability, MDVL's ROE is -2.39%, compared to HROWM's ROE of -1.04%. Regarding short-term risk, MDVL is more volatile compared to HROWM. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check HROWM's competition here
Latigo Biotherapeutics Inc. (NASDAQ: LTGO)
MDVL vs LTGO Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, LTGO has a market cap of 811.5M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while LTGO trades at $13.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas LTGO's P/E ratio is -5.35. In terms of profitability, MDVL's ROE is -2.39%, compared to LTGO's ROE of N/A. Regarding short-term risk, MDVL is more volatile compared to LTGO. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check LTGO's competition here
Helus Pharma Inc. (NASDAQ: HELP)
MDVL vs HELP Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, HELP has a market cap of 545.5M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while HELP trades at $8.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas HELP's P/E ratio is -2.11. In terms of profitability, MDVL's ROE is -2.39%, compared to HELP's ROE of -0.71%. Regarding short-term risk, MDVL is more volatile compared to HELP. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check HELP's competition here
Sinovac Biotech Ltd. (NASDAQ: SVA)
MDVL vs SVA Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, SVA has a market cap of 464.9M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while SVA trades at $6.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas SVA's P/E ratio is -5.68. In terms of profitability, MDVL's ROE is -2.39%, compared to SVA's ROE of -0.01%. Regarding short-term risk, MDVL is more volatile compared to SVA. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check SVA's competition here
Clinuvel Pharmaceuticals Ltd. (NASDAQ: CUVL)
MDVL vs CUVL Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, CUVL has a market cap of 249.9M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while CUVL trades at $4.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas CUVL's P/E ratio is 10.68. In terms of profitability, MDVL's ROE is -2.39%, compared to CUVL's ROE of N/A. Regarding short-term risk, MDVL is more volatile compared to CUVL. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check CUVL's competition here
High Tide Inc. (NASDAQ: HITI)
MDVL vs HITI Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, HITI has a market cap of 230.9M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while HITI trades at $2.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas HITI's P/E ratio is -9.57. In terms of profitability, MDVL's ROE is -2.39%, compared to HITI's ROE of -0.36%. Regarding short-term risk, MDVL is more volatile compared to HITI. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check HITI's competition here
Bristol-Myers Squibb Company Ce (NYSE: CELG-RI)
MDVL vs CELG-RI Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, CELG-RI has a market cap of 194.1M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while CELG-RI trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas CELG-RI's P/E ratio is N/A. In terms of profitability, MDVL's ROE is -2.39%, compared to CELG-RI's ROE of +0.44%. Regarding short-term risk, MDVL is more volatile compared to CELG-RI. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check CELG-RI's competition here
Electra Therapeutics Inc. (NASDAQ: ETRA)
MDVL vs ETRA Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, ETRA has a market cap of 155.1M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while ETRA trades at $7.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas ETRA's P/E ratio is -2.76. In terms of profitability, MDVL's ROE is -2.39%, compared to ETRA's ROE of N/A. Regarding short-term risk, MDVL is more volatile compared to ETRA. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check ETRA's competition here
TRex Bio Inc. (NASDAQ: TRXB)
MDVL vs TRXB Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, TRXB has a market cap of 114.4M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while TRXB trades at $13.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas TRXB's P/E ratio is -5.56. In terms of profitability, MDVL's ROE is -2.39%, compared to TRXB's ROE of N/A. Regarding short-term risk, MDVL is more volatile compared to TRXB. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check TRXB's competition here
Atlantic International Corp. (NASDAQ: ATLN)
MDVL vs ATLN Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, ATLN has a market cap of 68.6M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while ATLN trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas ATLN's P/E ratio is -0.68. In terms of profitability, MDVL's ROE is -2.39%, compared to ATLN's ROE of -83.20%. Regarding short-term risk, MDVL is more volatile compared to ATLN. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check ATLN's competition here
Citius Oncology, Inc. (NASDAQ: CTOR)
MDVL vs CTOR Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, CTOR has a market cap of 55.2M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while CTOR trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas CTOR's P/E ratio is -1.26. In terms of profitability, MDVL's ROE is -2.39%, compared to CTOR's ROE of -1.03%. Regarding short-term risk, MDVL is more volatile compared to CTOR. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check CTOR's competition here
Retension Pharmaceuticals Inc. (NASDAQ: RTSN)
MDVL vs RTSN Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, RTSN has a market cap of 43.6M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while RTSN trades at $11.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas RTSN's P/E ratio is -4.45. In terms of profitability, MDVL's ROE is -2.39%, compared to RTSN's ROE of N/A. Regarding short-term risk, MDVL is more volatile compared to RTSN. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check RTSN's competition here
Rite Aid Corporation (NYSE: RAD)
MDVL vs RAD Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, RAD has a market cap of 36.8M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while RAD trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas RAD's P/E ratio is -0.05. In terms of profitability, MDVL's ROE is -2.39%, compared to RAD's ROE of +2.76%. Regarding short-term risk, MDVL is more volatile compared to RAD. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check RAD's competition here
Damora Therapeutics, Inc. (NASDAQ: GLTO)
MDVL vs GLTO Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, GLTO has a market cap of 34.5M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while GLTO trades at $21.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas GLTO's P/E ratio is -1.78. In terms of profitability, MDVL's ROE is -2.39%, compared to GLTO's ROE of -0.83%. Regarding short-term risk, MDVL is more volatile compared to GLTO. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check GLTO's competition here
Cosmos Health Inc. (NASDAQ: COSM)
MDVL vs COSM Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, COSM has a market cap of 31.1M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while COSM trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas COSM's P/E ratio is -0.42. In terms of profitability, MDVL's ROE is -2.39%, compared to COSM's ROE of -1.19%. Regarding short-term risk, MDVL is more volatile compared to COSM. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check COSM's competition here
Nasus Pharma Ltd. (AMEX: NSRX)
MDVL vs NSRX Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, NSRX has a market cap of 27.6M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while NSRX trades at $3.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas NSRX's P/E ratio is -4.44. In terms of profitability, MDVL's ROE is -2.39%, compared to NSRX's ROE of -1.59%. Regarding short-term risk, MDVL is more volatile compared to NSRX. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check NSRX's competition here
SCYNEXIS, Inc. (NASDAQ: SCYX)
MDVL vs SCYX Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, SCYX has a market cap of 24M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while SCYX trades at $3.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas SCYX's P/E ratio is -1.11. In terms of profitability, MDVL's ROE is -2.39%, compared to SCYX's ROE of -0.21%. Regarding short-term risk, MDVL is more volatile compared to SCYX. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check SCYX's competition here
Pomdoctor Limited (NASDAQ: POM)
MDVL vs POM Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, POM has a market cap of 16.4M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while POM trades at $1.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas POM's P/E ratio is -0.28. In terms of profitability, MDVL's ROE is -2.39%, compared to POM's ROE of +0.80%. Regarding short-term risk, MDVL is more volatile compared to POM. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check POM's competition here
Biofrontera Inc. (NASDAQ: BFRI)
MDVL vs BFRI Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, BFRI has a market cap of 13M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while BFRI trades at $0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas BFRI's P/E ratio is -1.59. In terms of profitability, MDVL's ROE is -2.39%, compared to BFRI's ROE of -1.28%. Regarding short-term risk, MDVL is more volatile compared to BFRI. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check BFRI's competition here
Cerenome, Inc. (NASDAQ: CNSY)
MDVL vs CNSY Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, CNSY has a market cap of 12.9M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while CNSY trades at $1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas CNSY's P/E ratio is -0.41. In terms of profitability, MDVL's ROE is -2.39%, compared to CNSY's ROE of -3.94%. Regarding short-term risk, MDVL is more volatile compared to CNSY. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check CNSY's competition here
Azora Therapeutics, Inc. (NASDAQ: AZR)
MDVL vs AZR Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, AZR has a market cap of 10.4M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while AZR trades at $3.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas AZR's P/E ratio is -0.24. In terms of profitability, MDVL's ROE is -2.39%, compared to AZR's ROE of N/A. Regarding short-term risk, MDVL is more volatile compared to AZR. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check AZR's competition here
China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD)
MDVL vs CJJD Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, CJJD has a market cap of 9.9M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while CJJD trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas CJJD's P/E ratio is -0.46. In terms of profitability, MDVL's ROE is -2.39%, compared to CJJD's ROE of -0.25%. Regarding short-term risk, MDVL is more volatile compared to CJJD. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check CJJD's competition here
SunLink Health Systems, Inc. (AMEX: SSY)
MDVL vs SSY Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, SSY has a market cap of 7.9M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while SSY trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas SSY's P/E ratio is -2.86. In terms of profitability, MDVL's ROE is -2.39%, compared to SSY's ROE of -0.09%. Regarding short-term risk, MDVL is more volatile compared to SSY. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check SSY's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
MDVL vs SCNX Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, SCNX has a market cap of 5.3M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while SCNX trades at $3.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas SCNX's P/E ratio is -1.54. In terms of profitability, MDVL's ROE is -2.39%, compared to SCNX's ROE of -0.54%. Regarding short-term risk, MDVL is more volatile compared to SCNX. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check SCNX's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMS)
MDVL vs BGMS Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, BGMS has a market cap of 5M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while BGMS trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas BGMS's P/E ratio is -0.25. In terms of profitability, MDVL's ROE is -2.39%, compared to BGMS's ROE of -0.32%. Regarding short-term risk, MDVL is more volatile compared to BGMS. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check BGMS's competition here
Eocene Ltd. (NASDAQ: EOCN)
MDVL vs EOCN Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, EOCN has a market cap of 2.8M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while EOCN trades at $2.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas EOCN's P/E ratio is -0.19. In terms of profitability, MDVL's ROE is -2.39%, compared to EOCN's ROE of N/A. Regarding short-term risk, MDVL is more volatile compared to EOCN. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check EOCN's competition here
Paranovus Entertainment Technology Ltd. (NASDAQ: PAVS)
MDVL vs PAVS Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, PAVS has a market cap of 2.7M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while PAVS trades at $3.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas PAVS's P/E ratio is -0.03. In terms of profitability, MDVL's ROE is -2.39%, compared to PAVS's ROE of -0.46%. Regarding short-term risk, MDVL is more volatile compared to PAVS. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check PAVS's competition here
ETHZilla Corporation Warrant (NASDAQ: ATNFW)
MDVL vs ATNFW Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, ATNFW has a market cap of 2.6M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while ATNFW trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas ATNFW's P/E ratio is N/A. In terms of profitability, MDVL's ROE is -2.39%, compared to ATNFW's ROE of -2.15%. Regarding short-term risk, MDVL is more volatile compared to ATNFW. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check ATNFW's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMSP)
MDVL vs BGMSP Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, BGMSP has a market cap of 2.4M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while BGMSP trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas BGMSP's P/E ratio is -0.84. In terms of profitability, MDVL's ROE is -2.39%, compared to BGMSP's ROE of -0.32%. Regarding short-term risk, MDVL is more volatile compared to BGMSP. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check BGMSP's competition here
AstraZeneca PLC ADRhedged (AMEX: AZNH)
MDVL vs AZNH Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, AZNH has a market cap of 1.6M. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while AZNH trades at $53.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas AZNH's P/E ratio is 38.35. In terms of profitability, MDVL's ROE is -2.39%, compared to AZNH's ROE of +0.00%. Regarding short-term risk, MDVL is more volatile compared to AZNH. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check AZNH's competition here
Aspire Biopharma Holdings, Inc. (NASDAQ: ASBP)
MDVL vs ASBP Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, ASBP has a market cap of 842.2K. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while ASBP trades at $7.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas ASBP's P/E ratio is -0.31. In terms of profitability, MDVL's ROE is -2.39%, compared to ASBP's ROE of +19.93%. Regarding short-term risk, MDVL is more volatile compared to ASBP. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check ASBP's competition here
Biofrontera Inc. (NASDAQ: BFRIW)
MDVL vs BFRIW Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, BFRIW has a market cap of 796.7K. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while BFRIW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas BFRIW's P/E ratio is N/A. In terms of profitability, MDVL's ROE is -2.39%, compared to BFRIW's ROE of -1.28%. Regarding short-term risk, MDVL is more volatile compared to BFRIW. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check BFRIW's competition here
Leafly Holdings, Inc. (NASDAQ: LFLYW)
MDVL vs LFLYW Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, LFLYW has a market cap of 299.9K. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while LFLYW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas LFLYW's P/E ratio is -0.00. In terms of profitability, MDVL's ROE is -2.39%, compared to LFLYW's ROE of +0.42%. Regarding short-term risk, MDVL is more volatile compared to LFLYW. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check LFLYW's competition here
Aspire Biopharma Holdings, Inc. (NASDAQ: ASBPW)
MDVL vs ASBPW Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, ASBPW has a market cap of 149.5K. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while ASBPW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas ASBPW's P/E ratio is N/A. In terms of profitability, MDVL's ROE is -2.39%, compared to ASBPW's ROE of +19.93%. Regarding short-term risk, MDVL is less volatile compared to ASBPW. This indicates lower risk in terms of short-term price fluctuations for MDVL.Check ASBPW's competition here
ProPhase Labs, Inc. (NASDAQ: PRPH)
MDVL vs PRPH Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, PRPH has a market cap of 91.1K. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while PRPH trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas PRPH's P/E ratio is N/A. In terms of profitability, MDVL's ROE is -2.39%, compared to PRPH's ROE of -13.59%. Regarding short-term risk, MDVL is more volatile compared to PRPH. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check PRPH's competition here
Orexigen Therapeutics, Inc. (NASDAQ: OREX)
MDVL vs OREX Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, OREX has a market cap of 0. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while OREX trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas OREX's P/E ratio is -0.14. In terms of profitability, MDVL's ROE is -2.39%, compared to OREX's ROE of -0.54%. Regarding short-term risk, MDVL is more volatile compared to OREX. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check OREX's competition here
Shire plc (NASDAQ: SHPG)
MDVL vs SHPG Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, SHPG has a market cap of 0. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while SHPG trades at $179.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas SHPG's P/E ratio is 11.35. In terms of profitability, MDVL's ROE is -2.39%, compared to SHPG's ROE of +0.13%. Regarding short-term risk, MDVL is more volatile compared to SHPG. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check SHPG's competition here
Caraco Pharmaceutical Laboratories Ltd (AMEX: CPD)
MDVL vs CPD Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, CPD has a market cap of 0. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while CPD trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas CPD's P/E ratio is N/A. In terms of profitability, MDVL's ROE is -2.39%, compared to CPD's ROE of N/A. Regarding short-term risk, MDVL is more volatile compared to CPD. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check CPD's competition here
POZEN Inc. (NASDAQ: POZN)
MDVL vs POZN Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, POZN has a market cap of 0. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while POZN trades at $5.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas POZN's P/E ratio is N/A. In terms of profitability, MDVL's ROE is -2.39%, compared to POZN's ROE of +0.61%. Regarding short-term risk, MDVL is more volatile compared to POZN. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check POZN's competition here
Express Scripts Holding Company (NASDAQ: ESRX)
MDVL vs ESRX Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, ESRX has a market cap of 0. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while ESRX trades at $92.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas ESRX's P/E ratio is 10.69. In terms of profitability, MDVL's ROE is -2.39%, compared to ESRX's ROE of +0.26%. Regarding short-term risk, MDVL is more volatile compared to ESRX. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check ESRX's competition here
Impax Laboratories, Inc. (NASDAQ: IPXL)
MDVL vs IPXL Comparison November 2026
MedAvail Holdings, Inc. (NASDAQ: MDVL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDVL stands at 2.9M. In comparison, IPXL has a market cap of 0. Regarding current trading prices, MDVL is priced at $1.80 on the NASDAQ, while IPXL trades at $18.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDVL currently has a P/E ratio of -0.05, whereas IPXL's P/E ratio is -10.11. In terms of profitability, MDVL's ROE is -2.39%, compared to IPXL's ROE of -1.16%. Regarding short-term risk, MDVL is more volatile compared to IPXL. This indicates higher risk in terms of short-term price fluctuations for MDVL.Check IPXL's competition here